US 11840532
Modulators of THR-β and methods of use thereof
granted A61KA61K45/06A61P
Quick answer
US patent 11840532 (Modulators of THR-β and methods of use thereof) held by Aligos Therapeutics, Inc. expires Mon Dec 07 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Aligos Therapeutics, Inc.
- Grant date
- Tue Dec 12 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 07 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 12
- CPC classes
- A61K, A61K45/06, A61P, A61P1/16, A61P1/18